enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.660
-0.010 (-0.60%)
Oct 21, 2026, 11:01 AM EDT - Market open
enGene Therapeutics Employees
As of October 31, 2025, enGene Therapeutics had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year. That makes enGene Therapeutics the 32,561st largest employer in the world and 4,231st in the United States.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,589,756
Market Cap
111.25M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
| Jul 31, 2023 | 33 | - | - | 33 | 0 |
| Apr 30, 2023 | 33 | - | - | 30 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Seer, Inc. | 124 |
| Foghorn Therapeutics | 106 |
| Genelux | 26 |
| TuHURA Biosciences | 22 |
| Spruce Biosciences | 22 |
| Tevogen | 18 |
| Outlook Therapeutics | 17 |
ENGN News
- 6 days ago - enGene Therapeutics Transcript: KOL event - Transcripts
- 6 days ago - enGene Therapeutics Slides: KOL event - Filings
- 8 days ago - enGene to Host KOL Webinar on October 15, 2026 - Business Wire
- 5 weeks ago - enGene Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 weeks ago - enGene Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - enGene Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - enGene Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 6 weeks ago - enGene Reports Third Quarter 2026 Financial Results and Provides Business Update - Business Wire